Rekah Pharmaceutical Industry Ltd.'s latest marketcap:
As of 07/28/2025, Rekah Pharmaceutical Industry Ltd.'s market capitalization has reached $39.77 M. According to our data, Rekah Pharmaceutical Industry Ltd. is the 31711th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 39.77 M |
| Revenue (ttm) | 91.86 M |
| Net Income (ttm) | 773,747.43 |
| Shares Out | 11.41 M |
| EPS (ttm) | 0.07 |
| Forward PE | 0.00 |
| Ex-Dividend Date | 04/06/2022 |
| Earnings Date | 08/27/2025 |
Rekah Pharmaceutical Industry Ltd.'s yearly market capitalization.
| Date | Market Cap(₪) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 07/28/2025 | ₪133.44 M | $39.77 M | -10.64% | 31711 |
| 12/31/2024 | ₪151.24 M | $41.53 M | -10.35% | 29266 |
| 12/31/2023 | ₪168.71 M | $46.45 M | -3.96% | 28267 |
| 12/29/2022 | ₪175.67 M | $49.9 M | -33.89% | 26872 |
| 12/30/2021 | ₪265.73 M | $85.52 M | -13.13% | 24108 |
| 12/31/2020 | ₪305.91 M | $94.96 M | 34.2% | 20917 |
| 12/31/2019 | ₪227.95 M | $65.86 M | -22.45% | 20344 |
| 12/31/2018 | ₪293.93 M | $78.42 M | -14.21% | 18542 |
| 12/31/2017 | ₪342.6 M | $98.27 M | 69.43% | 18072 |
| 12/29/2016 | ₪202.2 M | $52.38 M | 22.84% | 19130 |
Company Profile
About Rekah Pharmaceutical Industry Ltd.
Rekah Pharmaceutical Industry Ltd. is a leading manufacturer and distributor of pharmaceuticals, cosmetics, vitamins, nutritional supplements, and medical devices in Israel. Established in 1947 and headquartered in Holon, the company is dedicated to providing high-quality healthcare solutions.
Product Portfolio
Rekah offers a diverse range of products, including:
- Steroid tablets for various therapeutic needs
- Antibiotics, including penicillin and cephalosporin
- Eye care solutions such as drops and ointments for allergies, infections, and dryness
- Baby products tailored for infant care
- Dermatological preparations for skin health
Therapeutic Applications
The company's portfolio includes both generic Rx and OTC drugs, covering a wide spectrum of therapeutic areas such as:
- Urinary tract pain
- Steroid anti-inflammatories
- Cough, expectoration, and bronchitis
- Motion sickness
- Runny nose and congestion
- Skin disinfection, wounds, burns, and insect bites
- Fever and pain relief
- Oral care
- Depression and anxiety
- Muscle and joint pain
- Anemia and nutritional deficits
- Ear pain
- Specialized products for babies and children
With decades of experience, Rekah Pharmaceutical Industry Ltd. continues to innovate and serve the healthcare needs of its customers.
Frequently Asked Questions
-
What is Rekah Pharmaceutical Industry Ltd.'s (TLV-REKA) current market cap?As of 07/28/2025, Rekah Pharmaceutical Industry Ltd. (including the parent company, if applicable) has an estimated market capitalization of $39.77 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Rekah Pharmaceutical Industry Ltd. (TLV-REKA) rank globally by market cap?Rekah Pharmaceutical Industry Ltd. global market capitalization ranking is approximately 31711 as of 07/28/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.